Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Prepaid Assets (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 13 years of Prepaid Assets data on record, last reported at $26.0 million in Q3 2025.

  • For Q3 2025, Prepaid Assets rose 46.82% year-over-year to $26.0 million; the TTM value through Sep 2025 reached $26.0 million, up 46.82%, while the annual FY2024 figure was $18.2 million, 101.1% up from the prior year.
  • Prepaid Assets reached $26.0 million in Q3 2025 per AMPH's latest filing, up from $20.3 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $26.0 million in Q3 2025 and bottomed at $5.9 million in Q2 2023.
  • Average Prepaid Assets over 5 years is $10.5 million, with a median of $7.6 million recorded in 2022.
  • Peak YoY movement for Prepaid Assets: dropped 29.41% in 2021, then soared 186.04% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $7.3 million in 2021, then grew by 3.97% to $7.6 million in 2022, then rose by 19.75% to $9.1 million in 2023, then skyrocketed by 101.1% to $18.2 million in 2024, then surged by 42.86% to $26.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $26.0 million in Q3 2025, $20.3 million in Q2 2025, and $17.8 million in Q1 2025.